Hong Kong Casino Stocks Rise as Macau Gaming Revenue Notches Best January Since 2020
By Kimberley Kao
Hong Kong-listed casino stocks rose after Macau's gaming revenue posted its second-best monthly performance since the pandemic, helped by increasing numbers of visitors to the Asian gambling hub.
Gross gaming revenue rose 67% in January from a year earlier to 19.34 billion patacas ($2.40 billion), Macau's gaming regulator said Thursday. That ranks just behind October's revenue as the highest level since January 2020.
Shares of gaming companies handily beat a 0.5% rise in Hong Kong's benchmark index. Shares of Melco International ended 6.9% higher, while Galaxy Entertainment, MGM China, Wynn Macau and Sands China added 5.9%, 5.7%, 4.1% and 4.2%, respectively.
The January revenue "defied normal seasonality" and slightly beat forecasts, Citi analysts wrote in a research note.
Visitors to Macau nearly quintupled in 2023 to 28.2 million people, according to government data. That is a step closer to prepandemic levels; 39.4 million people visited in 2019.
Analysts at S&P Global Ratings forecast Macau's mass-market gaming revenue this year to outperform 2019 pre-Covid levels by 5%-15%, according to a recent report. They also expect a 20%-30% increase in mass revenue, driven by increased visitors and expanded hotel capacity.
"Positive trends in the mass market will help operators further recover Ebitda and cash flows, and support deleveraging," Aras Poon, an associate director with S&P, said in an email.
Write to Kimberley Kao at kimberley.kao@wsj.com
(END) Dow Jones Newswires
February 01, 2024 06:18 ET (11:18 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth